RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-9.15%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$233M
AUM Growth
+$233M
(+16%)
Cap. Flow
+$43M
Cap. Flow
% of AUM
18.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$43M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $153M | 64.09% |
1,111,111
| – | – |
|
|
2
BioCryst Pharmaceuticals
BCRX
$1.74B
| $43M | 18% |
+3,846,154
| New | +$43M |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $22.9M | 9.59% |
9,166,667
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $13.5M | 5.65% |
3,700
| – | – |
|